Psychedelics Google co-founder invests millions in ibogaine research startup Soneira Sergey Brin's Catalyst4 fund, created with capital from his former Tesla stake, will inject over C$20.5 million Rowan DunneJuly 22, 2024
Psychedelics Psychedelic drugs for therapy: history, effectiveness, legal status The Department of Veteran Affairs, or VA, is quietly working on getting ecstasy approved for therapeutic use Adeline EeMay 30, 2024
Psychedelics Portland VA opens psychedelic therapy clinic for mental health and substance use disorders Two clinical trials are under way at the Social Neuroscience & Psychotherapy Lab Rowan DunneApril 2, 2024
Medical and Pharmaceutical Investors flock to psychedelic start-ups Sovereign wealth funds Temasek and Mubadala engage in discussions to finance biotech ventures Zartasha MushtaqFebruary 12, 2024
Health & Wellness Microdosing LSD shows potential antidepressant effects in landmark study Results of the study were published in the journal Neuropsychopharmacology Zartasha MushtaqJanuary 20, 2024
Psychedelics Māori group receives first psilocybin cultivation license in NZ to treat substance use disorders The license was granted to Rua Bioscience, a medical cannabis company based in Tairāwhiti Gisborne Rowan DunneOctober 30, 2023
Research 71% of Canadian women say inflation is taking a toll on their mental health: MHRC survey 42 per cent of women who needed care, but didn’t access it, reported financial barriers as their reason compared to 21 per cent of... Natalia Buendia CalvilloOctober 6, 2023
Psychedelics California startup Tactogen gets U.S. patent for MDMA derivatives The company focuses on developing novel psychoactive drugs with more gentle effects Rowan DunneSeptember 27, 2023
Canada Filament and Jaguar’s joint venture Magdalena imports Peruvian coca leaves to Vancouver The leaves were obtained from the Empresa Nacional de la Coca (ENACO) -- Peru's only authorized distributor Rowan DunneSeptember 22, 2023
Psychedelics Sweden’s Norrsken Foundation launches $4.4M psychedelics mental health initiative Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research Rowan DunneSeptember 14, 2023